TLDR
- Prenetics raised $48M from investors like Kraken and GPTX to grow Bitcoin holdings.
- The company now holds 275 BTC after launching its daily 1 BTC purchase strategy.
- IM8 hit $100M revenue in 11 months and targets up to $200M in 2026.
- Total proceeds could reach $216M if all warrants in the round are exercised.
Prenetics Global, a health sciences company trading on the Nasdaq, has raised $48 million through an equity offering to grow its Bitcoin reserves and scale its supplement brand, IM8. The funding round drew interest from both crypto-focused institutions and high-profile individual investors. The company has also outlined a five-year target of holding $1 billion in Bitcoin and reaching $1 billion in annual revenue.
Equity Round Attracts Crypto and Strategic Investors
Prenetics Global announced on Monday that it secured $48 million in gross proceeds from an oversubscribed equity offering. The funding attracted crypto-native investors including Kraken, Exodus, GPTX by Jihan Wu, DL Holdings, and American Ventures. Existing backers such as professional tennis player Aryna Sabalenka and Hong Kong entrepreneur Adrian Cheng also increased their stakes.
The company stated that if all associated warrants are exercised, the total raise could reach $216 million. The funds will be used to support Prenetics’ growing Bitcoin treasury strategy and the global rollout of its supplement brand, IM8.
Prenetics’ shareholder base also includes former footballer David Beckham, who co-founded IM8 with the company. CEO Danny Yeung confirmed in a press release that the company will use the capital to “accelerate IM8’s global expansion while advancing our disciplined Bitcoin treasury initiatives.”
Bitcoin Treasury Strategy and Holdings
Prenetics began its Bitcoin treasury initiative in August 2025, with a stated goal of accumulating 1 BTC per day. As of October 27, the company held approximately 275 BTC, worth around $31 million based on current market prices.
With the fresh capital raised, Prenetics expects its total liquidity to reach $131 million. Yeung reiterated the firm’s long-term target of acquiring $1 billion in Bitcoin over the next five years. “We are committed to both innovation in health sciences and a strategic approach to digital assets,” Yeung said.
The strategy marks one of the more visible cases of a publicly listed health sciences firm incorporating Bitcoin accumulation into its corporate treasury approach. The company did not state whether it plans to expand its daily Bitcoin purchase volume following this raise.
IM8 Supplement Brand Performance
The supplement brand IM8, launched in partnership with David Beckham, is a core part of the company’s expansion strategy. Prenetics reported that IM8 generated $100 million in recurring revenue within 11 months of launch. It expects revenue to increase to between $160 million and $200 million in 2026.
The funds from the offering will help IM8 grow across new markets and invest in distribution, product development, and customer acquisition. The company stated it aims to support IM8’s international reach while continuing to build its health product portfolio.
The company sees the brand as a key growth driver alongside its digital health and genomic testing businesses. No details were provided on upcoming product releases or specific market entries, but management emphasized scaling as a near-term goal.
Market Reaction and Company Performance
Following the news of the equity raise, Prenetics’ stock fell by 21.96% on Monday, closing at $13.08. However, it rebounded by 4.51% in after-hours trading. Despite recent volatility, the stock has gained over 161% in the past six months.
Market analysts did not immediately issue new guidance, and the company has not commented on the stock’s short-term performance. The equity raise comes at a time when many firms in the health and tech sectors are exploring ways to align digital finance with traditional business models.
Prenetics continues to focus on long-term performance and balance sheet strength. It plans to allocate capital carefully across its treasury and operational priorities.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
